Thalidomide structure
Thalidomide
Thalidomide is initially promoted as a sedative, inhibits ereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties.
Find 13 Related Holders
Ningbo Liwah Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Inactive
-
Founded in:
1993-01-06 -
Country:
China -
Address:
Xinlian Village, Gaoqiao Town, Haishu District, Ningbo City, Zhejiang Province -
Tax NO.:
913302126102591167 -
Registered Funds:
236 million yuan -
Website:
-
Email:
ANDRULIS PHARMACEUTICALS CORP
United States
United States
API Registration Country
API Inactive
SIFAVITOR SPA
United States
United States
API Registration Country
API Inactive
Recommended Suppliers of Thalidomide
-
Amitychem
CN1 YR
Contact Supplier -
Hangzhou Raisun Import & Export Co Ltd
CN1 YR
Contact Supplier -
BOC Sciences
US1 YR
Contact Supplier -
GIHI CHEMICALS CO.,LIMITED
CN1 YR
Contact Supplier -
HANGZHOU LEAP CHEM CO., LTD.
CN1 YR
Contact Supplier